HUBEI PROVINCE, CHINA--(MARKET WIRE)--Jun 18, 2007 -- Benda Pharmaceutical, Inc. (“Benda”) (OTC BB:BPMA.OB - News), a China-based pharmaceutical company producing traditional Chinese and conventional medicines, as well as Gendicine®, the world’s first commercialized gene therapy medicine for the treatment of cancer, announced that it has increased its ownership in Shenzhen SiBiono Genetech Corporation (“SiBiono”).
